Advertisement

Topics

Pharma tech company granted $14.3m to deliver affordable vaccines

07:30 EDT 14 Jun 2019 | EPM Magazine

A pharma technology company has received a $14.3 million grant from the Bill & Melinda Gates Foundation to help increase the availability of measles and rubella (M&R) vaccines in low-and middle-income countries (LMICs).

Original Article: Pharma tech company granted $14.3m to deliver affordable vaccines

NEXT ARTICLE

More From BioPortfolio on "Pharma tech company granted $14.3m to deliver affordable vaccines"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Measles
Measles (morbilli, rubeola) is a highly infectious viral illness that can be very unpleasant and can sometimes lead to serious complications.  The initial symptoms of measles develop around 10 days after initial infection: a high temperature (...